ArticleAmerican journal of cancer research2022

The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenografts.

Tony Reid et al.PubMed ↗Full text ↗

No numbers read from the abstract.